Myocardial infarction (MI), commonly called a heart attack, occurs when blood flow to the heart muscle is suddenly blocked. This blockage causes tissue damage or death due to lack of oxygen. Diagnosis of MI relies heavily on clinical symptoms, electrocardiography (ECG), and biochemical markers. Among these, the elevation of certain enzymes in the blood provides crucial evidence of cardiac muscle injury. This article will detail which enzyme is elevated in myocardial infarction, how it is used diagnostically, and why it is clinically significant.
The Role of Enzymes in Myocardial Injury
Enzymes are proteins that facilitate biochemical reactions. In the context of MI, the death of myocardial cells leads to the release of specific enzymes into the bloodstream. These enzymes serve as biomarkers of cardiac injury. Their presence, timing, and concentration help determine the occurrence and extent of myocardial damage.
The Primary Enzyme Elevated in Myocardial Infarction: Troponin
The most specific and sensitive enzyme marker for myocardial infarction is cardiac troponin. It has become the gold standard in diagnosing MI.
What Is Troponin?
Troponin is a complex of three regulatory proteins—troponin I, T, and C—found in skeletal and cardiac muscle. Of these, troponin I (cTnI) and troponin T (cTnT) are specific to the heart. When cardiac cells are damaged, troponin is released into the bloodstream.
Troponin Levels in MI
In acute myocardial infarction, troponin levels begin to rise within 3–6 hours of injury. Peak levels are typically seen at 12–24 hours and may remain elevated for 7–14 days, depending on the extent of myocardial necrosis.
Why Troponin Is the Preferred Marker
- Highly specific to cardiac muscle
- Detectable even in small infarctions
- Remains elevated for a prolonged period
- Correlates well with prognosis and mortality
Other Enzymes Elevated in Myocardial Infarction
Although troponin is the most important enzyme for MI diagnosis today, other markers were historically used and may still be measured in some clinical settings.
Creatine Kinase-MB (CK-MB)
CK-MB is an isoenzyme of creatine kinase found primarily in heart muscle. It rises within 3–12 hours after MI onset, peaks at 24 hours, and returns to baseline within 48–72 hours. CK-MB is helpful in identifying reinfarction because of its shorter half-life.
CK-MB Limitations
- Less specific than troponin
- Can be elevated in skeletal muscle injury
- Not as sensitive for small infarcts
Lactate Dehydrogenase (LDH)
LDH is a general enzyme found in many tissues. LDH isoenzyme 1 (LDH-1) is elevated in myocardial infarction. It rises within 12–24 hours, peaks at 48–72 hours, and stays elevated for up to 10 days.
LDH Limitations
- Poor specificity
- Delayed peak makes it less useful in early diagnosis
Aspartate Aminotransferase (AST)
AST is another enzyme that increases after myocardial infarction. It rises 6–12 hours after MI, peaks at 24–48 hours, and normalizes within 3–7 days. It is not specific to cardiac tissue and may also rise in liver or muscle injury.
Comparative Timeline of Enzyme Elevation
| Enzyme | Rise (hours) | Peak (hours) | Return to Normal |
|---|---|---|---|
| Troponin | 3–6 | 12–24 | 7–14 days |
| CK-MB | 3–12 | 24 | 2–3 days |
| LDH | 12–24 | 48–72 | 10 days |
| AST | 6–12 | 24–48 | 3–7 days |
High-Sensitivity Troponin Assays (hs-cTn)
Modern assays can detect very low concentrations of troponin with high precision. High-sensitivity troponin (hs-cTn) tests enable earlier diagnosis of MI, sometimes within 1–2 hours of symptom onset.
Clinical Advantages
- Improved early diagnosis
- Better risk stratification
- Useful in patients with atypical symptoms
Troponin Elevation in Other Conditions
Although troponin is cardiac-specific, its elevation is not exclusive to myocardial infarction. Other causes include:
- Myocarditis
- Heart failure
- Pulmonary embolism
- Chronic kidney disease
- Sepsis
Therefore, elevated troponin must always be interpreted within clinical context and ECG findings.
Prognostic Role of Troponin
Troponin levels not only help in diagnosis but also in assessing prognosis. Higher levels are associated with:
- Increased risk of heart failure
- Higher short-term and long-term mortality
- More extensive myocardial damage
Serial Troponin Testing
Serial measurements improve diagnostic accuracy. A significant rise or fall in troponin levels over hours confirms acute myocardial injury. Guidelines often recommend testing at 0, 1, and 3 hours post-presentation.
Troponin in NSTEMI and STEMI
Troponin elevation is key in distinguishing between unstable angina and non-ST-elevation myocardial infarction (NSTEMI).
In ST-elevation myocardial infarction (STEMI), it supports ECG findings but is not necessary for initial diagnosis.
Troponin in Clinical Guidelines
Major guidelines, including those from the European Society of Cardiology and American College of Cardiology, endorse troponin as the preferred biomarker for MI diagnosis. High-sensitivity assays are strongly recommended for rapid triage in emergency settings.
Enzyme Testing in Resource-Limited Settings
In areas where troponin testing is unavailable, CK-MB and LDH may still be used. However, their limited specificity and sensitivity must be considered. Clinicians should always integrate clinical and ECG findings with biochemical data.
Conclusion
The most reliable and specific enzyme elevated in myocardial infarction is cardiac troponin. It has revolutionized the diagnosis and management of acute coronary syndromes. Other enzymes such as CK-MB, LDH, and AST also rise during MI but are less specific and used primarily in supporting roles or in limited-resource settings. Serial testing and interpretation in the clinical context are essential to making an accurate and timely diagnosis.
Related topics:
